Updated: January 9, 2026

Phentermine/Topiramate XR Side Effects: What to Expect and When to Call Your Doctor

Author

Peter Daggett

Summarize with AI

Most Common Side Effects in Adults
Side Effects in Adolescents (Ages 12–17)
Serious Warnings: When to Call Your Doctor Immediately
The Most Important Warning: Pregnancy
Tips for Managing Common Side Effects
The Bottom Line

Qsymia's most common side effects include tingling, dry mouth, and dizziness. Some are serious. Know what's normal and when to call your doctor on phentermine/topiramate XR.

Phentermine/topiramate extended-release (Qsymia) is a combination medication, and its side effects reflect both of its active ingredients: phentermine, a stimulant, and topiramate, an anticonvulsant. Understanding what side effects are common and expected versus what requires a call to your doctor is essential for staying on treatment safely.

Most Common Side Effects in Adults

In clinical trials of adult patients, the most frequently reported side effects occurring in at least 5% of patients and at least 1.5 times more often than placebo were:

Paraesthesia ("pins and needles" or tingling) — caused by topiramate; usually affects hands, feet, and face; often fades with time

Dizziness — common, especially early in treatment; change positions slowly

Dysgeusia (altered or impaired taste) — foods may taste different; caused by topiramate's carbonic anhydrase inhibition

Insomnia — take Qsymia in the morning to reduce sleep disruption from phentermine's stimulant effect

Constipation — drink plenty of water; increase fiber intake if needed

Dry mouth — stay well hydrated; sugar-free gum or lozenges can help

Side Effects in Adolescents (Ages 12–17)

In the pediatric clinical trial, the most common adverse reactions (≥4% and greater than placebo) were different from the adult profile:

Depression

Dizziness

Arthralgia (joint pain)

Pyrexia (fever)

Influenza (flu-like symptoms)

Ligament sprain

Serious Warnings: When to Call Your Doctor Immediately

The following side effects require prompt medical attention:

Suicidal thoughts or behavior: Topiramate is associated with increased risk of suicidal ideation. Contact your doctor immediately if you experience depression, mood changes, or thoughts of self-harm. The risk can begin within the first week of treatment.

Rapid heart rate (tachycardia): Phentermine can increase heart rate. If you notice a consistently elevated pulse or heart palpitations, contact your provider.

Eye pain or vision changes: Acute myopia (sudden nearsightedness) and secondary angle-closure glaucoma are rare but serious. Seek immediate eye care if you experience sudden eye pain or blurred vision.

Metabolic acidosis symptoms: Topiramate inhibits carbonic anhydrase, which can lower blood bicarbonate levels. Symptoms include fatigue, rapid breathing, confusion, or abdominal discomfort. Your doctor will monitor bicarbonate with periodic labs.

Decreased sweating and overheating: Topiramate can impair sweating (anhidrosis), which raises risk of heat stroke. Stay well hydrated and avoid prolonged exposure to high temperatures during exercise.

Kidney stones: The carbonic anhydrase inhibition from topiramate can increase kidney stone risk. Drink plenty of water throughout the day.

Cognitive impairment: Some patients experience difficulty concentrating, word-finding problems, or slowed thinking (sometimes called "Dopamax" effect). Report significant cognitive changes to your doctor.

Serious skin reactions: Rare cases of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported. Stop Qsymia and seek immediate care if you develop a rash.

The Most Important Warning: Pregnancy

Qsymia is contraindicated in pregnancy. Topiramate is known to cause serious birth defects, including cleft lip and cleft palate, when taken during the first trimester. This is why the Qsymia REMS requires monthly pregnancy testing for patients who can become pregnant. If you become pregnant while taking Qsymia, stop immediately and contact your healthcare provider.

Tips for Managing Common Side Effects

Tingling: Usually improves over time. Staying well hydrated may help.

Insomnia: Always take in the morning, not at night. Avoid caffeine after noon.

Constipation: Increase water and fiber. If persistent, discuss with your doctor — a stool softener may be recommended.

Dry mouth: Sip water throughout the day. Dental hygiene is important — dry mouth can increase cavity risk.

The Bottom Line

Most patients tolerate Qsymia well, with tingling, dry mouth, and dizziness being the most common complaints — these typically improve after the first few weeks. The more serious risks (suicidal ideation, glaucoma, birth defects) require close monitoring but are rare when the medication is used as prescribed with proper REMS safety protocols. For information on drug interactions to avoid, see our companion guide: Phentermine/Topiramate XR Drug Interactions.

Frequently Asked Questions

The most commonly reported side effect in clinical trials is paraesthesia — a tingling or pins-and-needles sensation that usually affects the hands, feet, and face. This is caused by topiramate's carbonic anhydrase inhibition. It typically improves over the first few weeks of treatment and does not usually require stopping the medication.

Yes. Topiramate, one of the active ingredients in Qsymia, is associated with an increased risk of suicidal thoughts or behavior and depression. Monitor for mood changes, worsening depression, or unusual behavior changes — especially in the first weeks of treatment. Cognitive side effects like difficulty concentrating or word-finding problems ('Dopamax effect') have also been reported. Contact your doctor if these become significant.

Phentermine can increase heart rate. In clinical studies, Qsymia was associated with elevated heart rate compared to placebo. If you experience sustained rapid heartbeat or palpitations, contact your healthcare provider. The cardiovascular safety of Qsymia — specifically its effect on heart disease or stroke risk — has not been fully established in long-term outcomes studies.

Yes, exercise is encouraged as part of the weight management program with Qsymia. However, be cautious about overheating — topiramate can impair sweating (anhidrosis), increasing heat stroke risk during intense activity in hot weather. Stay well hydrated, exercise in cool environments when possible, and stop if you feel unusually hot or stop sweating during exercise.

Many common side effects — especially tingling, dizziness, and dry mouth — often improve within the first 4–8 weeks as your body adjusts to the medication. Insomnia typically resolves when the medication is taken in the morning. If side effects are severe or do not improve, discuss dose adjustment or alternative options with your doctor. Do not abruptly stop Qsymia 15/92 mg without tapering, as it can increase seizure risk.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards